AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / CHEMICALS & ALLIED PRODUCTS
The Chemours Company
XNYS · usd
SIC 2800 · CHEMICALS & ALLIED PRODUCTS
FIGI BBG005H82GC1
12.81▼ 0.22 (-1.69%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
13.03
Day's Range
12.58 – 13.08
52-Week Range
10.44 – 28.67
Volume
1.7M
Avg Volume
2.1M
Share Statistics
Shares Outstanding
Employees
5,700
Exchange
XNYS
Listed
2015-06-19
Share count as of July 30, 2026

The Chemours Company (CC) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about The Chemours Company (CC)
What is The Chemours Company's Market Cap?
The Chemours Company's Market Cap is $1.9B, based on as-reported figures from SEC (XBRL) filings.
What is The Chemours Company's Enterprise Value?
The Chemours Company's Enterprise Value is $5.1B, based on as-reported figures from SEC (XBRL) filings.
What is The Chemours Company's Price / Sales?
The Chemours Company's Price / Sales is 0.3×, based on as-reported figures from SEC (XBRL) filings.
What is The Chemours Company's EV / Revenue?
The Chemours Company's EV / Revenue is 0.9×, based on as-reported figures from SEC (XBRL) filings.
What is The Chemours Company's EV / EBITDA?
The Chemours Company's EV / EBITDA is 9.5×, based on as-reported figures from SEC (XBRL) filings.
What is The Chemours Company's Revenue (TTM)?
The Chemours Company's Revenue (TTM) is $5.8B, based on as-reported figures from SEC (XBRL) filings.
What is The Chemours Company's Net Income (TTM)?
The Chemours Company's Net Income (TTM) is -$304.0M, based on as-reported figures from SEC (XBRL) filings.
What is The Chemours Company's EBITDA?
The Chemours Company's EBITDA is $543.0M, based on as-reported figures from SEC (XBRL) filings.
What is The Chemours Company's Diluted EPS (TTM)?
The Chemours Company's Diluted EPS (TTM) is -2.02, based on as-reported figures from SEC (XBRL) filings.
What is The Chemours Company's EBITDA Margin?
The Chemours Company's EBITDA Margin is 9.4%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CCAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Segment information from Consolidated Statements of Operations:
Net sales
YoY growth-1.5%+1.0%-2.1%-0.9%
Cost of goods sold
Gross profit
% of revenue18.0%15.4%11.7%15.6%
Selling, general, and administrative expense
Research and development expense
Restructuring, asset-related, and other charges
Total other operating expenses
% of revenue31.4%13.5%12.1%9.3%
Equity in earnings of affiliates
Interest expense, net
Loss on extinguishment of debt——
Other income, net
Loss before income taxes
Provision for income taxes
Net loss
% of revenue-17.2%-2.1%-4.7%4.0%
Less: Net income attributable to non-controlling interests——
Net loss attributable to Chemours
% of revenue-17.2%-2.1%-4.6%4.0%
Basic (loss) earnings per share of common stock—
Diluted (loss) earnings per share of common stock—